J.M. Pascasio

1.7k total citations
46 papers, 594 citations indexed

About

J.M. Pascasio is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, J.M. Pascasio has authored 46 papers receiving a total of 594 indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Hepatology, 37 papers in Epidemiology and 13 papers in Surgery. Recurrent topics in J.M. Pascasio's work include Hepatitis C virus research (30 papers), Liver Disease Diagnosis and Treatment (26 papers) and Hepatitis B Virus Studies (19 papers). J.M. Pascasio is often cited by papers focused on Hepatitis C virus research (30 papers), Liver Disease Diagnosis and Treatment (26 papers) and Hepatitis B Virus Studies (19 papers). J.M. Pascasio collaborates with scholars based in Spain, Belgium and United States. J.M. Pascasio's co-authors include Javier Crespo, Miguel Ángel Gómez‐Bravo, Marı́a Buti, J.M. Sousa, José Luís Calleja, M.T. Ferrer, Thomas Vanwolleghem, Iurie Moscalu, John Fry and M. Prieto and has published in prestigious journals such as Gastroenterology, Journal of Hepatology and The American Journal of Gastroenterology.

In The Last Decade

J.M. Pascasio

46 papers receiving 583 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J.M. Pascasio Spain 14 508 420 160 68 67 46 594
Nancy L. Ascher United States 8 834 1.6× 689 1.6× 200 1.3× 95 1.4× 41 0.6× 9 924
Neelam Mohan India 13 254 0.5× 210 0.5× 219 1.4× 18 0.3× 85 1.3× 48 481
S. Pol France 11 571 1.1× 474 1.1× 44 0.3× 124 1.8× 99 1.5× 54 660
Faouzi Saliba France 9 380 0.7× 309 0.7× 323 2.0× 157 2.3× 64 1.0× 15 636
Manuel de Juan Burgueño Spain 7 436 0.9× 344 0.8× 122 0.8× 46 0.7× 13 0.2× 12 511
Mario Magnone United States 6 156 0.3× 236 0.6× 57 0.4× 73 1.1× 85 1.3× 14 364
Jay Hoofnagle United States 6 754 1.5× 627 1.5× 135 0.8× 59 0.9× 36 0.5× 9 828
Jeanne Serpaggi France 9 738 1.5× 697 1.7× 34 0.2× 18 0.3× 73 1.1× 9 799
L.-N. Yan China 15 342 0.7× 222 0.5× 317 2.0× 58 0.9× 12 0.2× 36 535
Marie-Claude Becker France 7 183 0.4× 156 0.4× 286 1.8× 17 0.3× 55 0.8× 10 478

Countries citing papers authored by J.M. Pascasio

Since Specialization
Citations

This map shows the geographic impact of J.M. Pascasio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J.M. Pascasio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J.M. Pascasio more than expected).

Fields of papers citing papers by J.M. Pascasio

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J.M. Pascasio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J.M. Pascasio. The network helps show where J.M. Pascasio may publish in the future.

Co-authorship network of co-authors of J.M. Pascasio

This figure shows the co-authorship network connecting the top 25 collaborators of J.M. Pascasio. A scholar is included among the top collaborators of J.M. Pascasio based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J.M. Pascasio. J.M. Pascasio is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fernández, Inmaculada, J.M. Pascasio, & Jordi Colmenero. (2020). Prophylaxis and treatment in liver transplantation. VII Consensus Document of the Spanish Society of Liver Transplantation. Gastroenterología y Hepatología (English Edition). 43(3). 169–177. 2 indexed citations
2.
García, Féderico, Raquel Domínguez‐Hernández, Marta Casado, et al.. (2019). La simplificación del proceso de diagnóstico de la hepatitis C crónica es una estrategia coste-efectiva. Enfermedades Infecciosas y Microbiología Clínica. 37(10). 634–641. 8 indexed citations
3.
García, Féderico, et al.. (2019). FRI-229-Reflex testing in patients with chronic hepatitis C in Spain improves healthcare outcomes and is cost effective. Journal of Hepatology. 70(1). e495–e496. 1 indexed citations
4.
Rodríguez, Manuel, J.M. Pascasio, Enrique Fraga, et al.. (2017). Tenofovir vs lamivudine plus adefovir in chronic hepatitis B: TENOSIMP-B study. World Journal of Gastroenterology. 23(41). 7459–7469. 6 indexed citations
5.
Bensusán, Israel Grilo, J.M. Pascasio, Francisco Órtega Ruiz, et al.. (2017). The utility of the macro-aggregated albumin lung perfusion scan in the diagnosis and prognosis of hepatopulmonary syndrome in cirrhotic patients candidates for liver transplantation. Revista Española de Enfermedades Digestivas. 109(5). 335–343. 8 indexed citations
6.
Sánchez‐Antolín, Gloria, Milagros Testillano, J.M. Pascasio, et al.. (2016). Efficacy and Safety of Therapy With Simeprevir and Sofosbuvir in Liver Transplant Recipients Infected by Hepatitis C Virus Genotype 4: Cohort Spanish Society of Liver Transplantation Cohort. Transplantation Proceedings. 48(9). 3013–3016. 2 indexed citations
7.
Fernández, Inmaculada, J.M. Pascasio, Carme Baliellas, et al.. (2016). Efficacy and tolerability of interferon-free antiviral therapy in kidney transplant recipients with chronic hepatitis C. Journal of Hepatology. 66(4). 718–723. 68 indexed citations
8.
Pascasio, J.M., Israel Grilo Bensusán, Francisco Órtega Ruiz, et al.. (2014). Prevalence and Severity of Hepatopulmonary Syndrome and Its Influence on Survival in Cirrhotic Patients Evaluated for Liver Transplantation. American Journal of Transplantation. 14(6). 1391–1399. 54 indexed citations
9.
Calleja, José Luís, J.M. Pascasio, Belén Ruíz‐Antorán, et al.. (2014). Safety and efficacy of triple therapy with peginterferon, ribavirin and boceprevir within an early access programme in Spanish patients with hepatitis C genotype 1 with severe fibrosis: SVRw12 analysis. Liver International. 35(1). 90–100. 15 indexed citations
10.
Varela, Marı́a, María Reig, Manuel de la Mata, et al.. (2009). Tratamiento del carcinoma hepatocelular en España. Análisis de 705 casos en 62 centros. Medicina Clínica. 134(13). 569–576. 39 indexed citations
11.
Gómez, Luis Miguel Marín, Miguel Ángel Gómez‐Bravo, L. Barrera Pulido, et al.. (2009). Evaluation of Clinical Safety of Conversion to Advagraf Therapy in Liver Transplant Recipients: Observational Study. Transplantation Proceedings. 41(6). 2184–2186. 19 indexed citations
12.
Santoyo, Julio Santoyo, Belinda Sánchez Pérez, Manuel de la Mata, et al.. (2009). Liver Transplantation for Hepatocellular Carcinoma: Results of a Multicenter Study With Common Priorization Criteria. Transplantation Proceedings. 41(3). 1009–1011. 4 indexed citations
13.
Cordero, Elisa, et al.. (2009). Estudio descriptivo de las complicaciones infecciosas en 109 receptores de trasplantes hepáticos consecutivos. Enfermedades Infecciosas y Microbiología Clínica. 27(4). 199–205. 6 indexed citations
14.
Martín, Eduardo Márquez, Luis Jara‐Palomares, Francisco Órtega Ruiz, et al.. (2008). Síndrome hepatopulmonar en pacientes con hepatopatía avanzada: estudio de 24 casos. Medicina Clínica. 130(3). 98–102. 3 indexed citations
15.
Pascasio, J.M., et al.. (2008). Prevalence of Hepatitis A and B Markers and Vaccine Indication in Cirrhotic Patients Evaluated for Liver Transplantation in Spain. Transplantation Proceedings. 40(9). 2946–2948. 2 indexed citations
16.
Mata, Manuel de la, Natividad Cuende, A Bernardos, et al.. (2006). Model for End-Stage Liver Disease Score-Based Allocation of Donors for Liver Transplantation: A Spanish Multicenter Experience. Transplantation. 82(11). 1429–1435. 37 indexed citations
17.
Sousa, J.M., Felipe Pareja-Ciuró, Cristina V. Torres, et al.. (2003). Comparison between levels of anti-HBS with a fixed administration dose of HBIG and a combination of HBIG and lamivudine for the prophylaxis of hepatitis B after liver transplantation. Transplantation Proceedings. 35(2). 723–724. 15 indexed citations
18.
Garduño, Eugenio, et al.. (2000). Splenic abscesses caused by Actinomyces meyeri in a patient with autoimmune hepatitis. Diagnostic Microbiology and Infectious Disease. 37(3). 213–214. 13 indexed citations
19.
Alcalde, María Martínez, et al.. (1996). Hepatotoxicity Due to Lysine Salt of Bendazac. Scandinavian Journal of Gastroenterology. 31(2). 206–208. 3 indexed citations
20.
Pascasio, J.M., et al.. (1992). [Prevalence of hepatitis C virus antibody in chronic HBsAg-negative non alcoholic hepatopathy].. PubMed. 81(2). 117–20. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026